Alpha-1, COPD Foundations Sponsor Workshop on Standardizing CT Scans for COPD
April 3, 2008
Bethesda. MD – The Alpha-1 Foundation and COPD Foundation are sponsoring a workshop this week for specialists from around the world to review the state of the art in CT Scan technology and arrive at a set of recommendations for future research on COPD.
The two-day workshop beginning Thursday is formally entitled “Quantitive Chest Tomography in COPD Research” and will involve both presentations and discussions by experts attending from as far away as Japan.
According to Alpha-1 Foundation Scientific Director Adam Wanner, MD, “Quantitative computed tomography has the potential to be a very important tool to study the genetics and pathogenesis of COPD, as well as the potential effect of therapeutic interventions. The central problem is, there is currently no standardized method for CT scanning in COPD.”
Wanner said he hopes information gathered at the workshop will ultimately serve as the basis for an international CT scanning standard.
The overall chair of the workshop is Harvey Coxson, MD, of the University of British Columbia, Vancouver, BC. Co-chairs are Stephen Rennard, MD, University of Nebraska Medical Center, Omaha; John Newell, MD, National Jewish Medical & Research Center, Denver, CO, and Jan Stolk, MD, of Leiden University Medical Center, Leiden, the Netherlands.
Workshop presenters include Drs. Coxson, Rennard and Newell; Martine Remy- Jardin, MD, of Albert-Calmette Hospital in Lille, France; and Masaharu Nishimura, MD, of Hokkaido University School of Medicine in Japan.
The Alpha-1 Foundation and COPD Foundation are grateful to the following organizations for providing sponsorship to support this workshop, the 10th installment of the Gordon L. Snider Critical Issues Workshop Series: AlphaNet, Arriva Pharmaceuticals, Baxter Healthcare, CSL Behring, Kamada Ltd., Roche Pharmaceuticals, Spiration Inc. and Talecris Biotherapeutics.
About the Alpha-1 Foundation:
The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha-1 Antitrypsin Deficiency. For more information, please visit: http://www.alphaone.org.
Contact: Bob Campbell
(305) 567-9888, ext. 230
About the COPD Foundation:
The COPD Foundation is dedicated to developing and supporting programs which improve the quality of life through research, education, early diagnosis, and enhanced therapy for persons whose lives are impacted by Chronic Obstructive Pulmonary Disease. For more information, please visit: http://www.copdfoundation.org/.
Ifdy Perez
(305) 567-9888, ext. 398